Antidementia drug
Antidementia drugs are a class of pharmacological agents used to treat the symptoms of dementia, a broad category of brain diseases that cause a long-term and often gradual decrease in the ability to think and remember. These drugs are designed to improve cognitive function, manage behavioral symptoms, and slow or delay the progression of the disease.
Types of Antidementia Drugs[edit | edit source]
There are two main types of antidementia drugs: cholinesterase inhibitors and NMDA receptor antagonists.
Cholinesterase Inhibitors[edit | edit source]
Cholinesterase inhibitors work by increasing the levels of acetylcholine, a neurotransmitter that is important for memory and learning, in the brain. They are primarily used to treat Alzheimer's disease, but can also be used for other forms of dementia. Examples of cholinesterase inhibitors include Donepezil, Rivastigmine, and Galantamine.
NMDA Receptor Antagonists[edit | edit source]
NMDA receptor antagonists work by blocking the action of glutamate, a neurotransmitter that can cause damage to brain cells when present in excessive amounts. The only NMDA receptor antagonist currently approved for the treatment of Alzheimer's disease is Memantine.
Effectiveness[edit | edit source]
The effectiveness of antidementia drugs varies from person to person. Some people may experience a significant improvement in their symptoms, while others may only see a slight benefit. It's also important to note that these drugs do not cure dementia, but rather manage its symptoms.
Side Effects[edit | edit source]
Like all medications, antidementia drugs can cause side effects. Common side effects include nausea, vomiting, loss of appetite, and increased frequency of bowel movements. More serious side effects can include a slow heart rate, fainting, and seizures.
Future Research[edit | edit source]
Research is ongoing to find new and more effective antidementia drugs. This includes exploring other neurotransmitter systems, investigating the role of inflammation in dementia, and developing drugs that can target the underlying disease process.
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
 | This article about a neurology is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
